The SMG6 gene helps your cells check RNA messages and clear out broken instructions before they are used to make proteins. This gene plays an important role in a quality control step called nonsense-mediated mRNA decay (a way cells remove faulty protein instructions). If SMG6 does not work well, abnormal messages can build up and may disrupt how cells function and grow. Many variants are harmless, while a few may change how the gene works and, in certain cases, contribute to developmental or health problems. SMG6 is mainly known in genetics and cell biology, rather than through a widely publicized celebrity story.

What is a gene?

A gene is a stretch of DNA that carries instructions your cells use to make molecules or guide activities in the body. Some genes provide the directions for building proteins, which are key parts that help cells do their jobs. Other genes are more involved in regulating when certain processes happen, where they take place, and how active they are. Taken as a whole, genes affect how your body grows and works, and they can influence your response to things like diet, stress, or medicines. For a deeper look at this subject, you can learn more in the LearnHub.

Overview

SMG6

Gene function

What if the gene works

The SMG6 gene helps your cells spot messenger RNA messages that have mistakes, such as an early stop signal. It then helps break down those faulty messages so your body can make proteins more reliably.

Risk

What if the gene does not work

When the SMG6 gene doesn’t work well, cells may struggle to clear faulty RNA messages, disrupting early development. Depending on the DNA change, symptoms can range from learning and speech delays to early-onset developmental disability with microcephaly and poor growth.

Treatment

What does that mean for your treatment

No drug therapy targets the SMG6 gene yet, so care is guided by symptoms and findings. Results can guide monitoring and supportive care planning, including transfusions or stem cell transplant in selected cases, but usually do not predict medication response.

Gene function

What if the gene works

Every day, your cells make thousands of RNA messages that act like instructions for building proteins. A key part of staying healthy is clearing out messages that are incomplete or contain the wrong “stop” signal. The SMG6 gene supports this routine quality-control work so cells can rely on more accurate instructions.

Faulty message cleanup

One of the SMG6 gene’s main jobs is RNA message quality control through nonsense-mediated mRNA decay (a cleanup system for messages with an early stop signal). It helps cut and remove these faulty messages so they do not get used as protein-building instructions.

Message level control

SMG6 also helps fine-tune normal gene activity by controlling how long certain RNA messages stick around. This supports balanced protein production, such as keeping some instructions brief and letting others persist longer when needed.

What is a variant?

A genetic variant refers to a minor difference in the DNA code within a gene. These differences are widespread and help explain normal variation among people, such as differences in physical traits, metabolism, or how the body reacts to environmental factors. Many variants do not cause any clear changes and are part of typical genetic diversity. In certain situations, though, a variant can affect how a gene works in a more meaningful way and may play a role in, or lead to, a genetic condition.

Variant illustration

Genetic variants

What if the gene does not work

Changes in the SMG6 gene can weaken the body’s ability to clear out faulty genetic “messages,” so cells may make proteins that are the wrong length or don’t work as expected. Depending on the variant, this may affect early development, learning, growth, or the way certain organs form. SMG6 gene variants can range from milder changes that leave some activity to severe mutations that greatly reduce function. This range can influence when signs appear, how noticeable they are, and which features show up.

How variants are linked to conditions

Variants in the SMG6 gene are most often discussed in the setting of cancer sequencing, where SMG6 gene variants in tumor tissue have been reported across several cancer types. In large research studies, SMG6 changes have been seen in cancers such as colorectal cancer and endometrial cancer, usually as acquired (tumor-only) findings rather than inherited ones. These observations can point to shared cancer pathways in a tumor, but they do not, by themselves, diagnose an inherited cancer condition.

A variant is not necessarily a diagnosis

Genetic variants are a typical feature of human biology, and they occur frequently across the general population. In most cases, these variants do not directly change a person’s health and instead reflect normal human diversity. With many genes, having a variant that has been linked to a condition points to a potential association rather than a certain diagnosis, particularly when many genes and environmental influences play a role. In other situations, though, one well-understood variant in a particular gene can be enough to confirm a diagnosis.

Dr. Wallerstorfer Dr. Wallerstorfer

Are there things that can increase or change my risk?

If you carry a harmful change in the SMG6 gene, the chance of developing related health problems is usually driven mainly by that genetic change, and age and family history can affect when issues show up. There is not enough evidence to say that diet, supplements, or exercise lower SMG6-related risk. Regular checkups and following any recommended monitoring can help catch problems early and prevent complications.

Inheritance of SMG6 variants

Most known health conditions linked to changes in the SMG6 gene follow an autosomal recessive pattern, meaning a person typically needs two nonworking copies to be affected. In this SMG6 gene inheritance pattern, parents often carry one changed copy without symptoms and can pass it to any child, regardless of sex. When both parents are carriers, each pregnancy has a 25% chance of an affected child.

What does my SMG6 result mean for my family?

Seek medical advice if your SMG6 result is labeled “pathogenic” or “likely pathogenic,” or if it is “uncertain” and your family has a pattern of serious blood, immune, or unexplained long-term health problems. A clinician or genetics specialist can explain who in the family may be at higher chance and what follow-up makes sense. Share the result before major treatments, since it can sometimes affect care choices.


Genetic information


Genetic testing

How you find out about variants

Genetic testing can identify changes in the SMG6 gene by analyzing DNA from a blood sample, saliva, or a cheek swab. SMG6 genetic testing for variants typically uses sequencing, which reads the gene’s code and compares it with a reference to spot differences. Results usually classify variants by how likely they are to affect health.

When should I consider getting a genetic test?

Consider testing for changes in the SMG6 gene when you or a close relative has an unexplained, possibly inherited health problem and your clinician thinks SMG6 could be involved. Testing can also be useful after genetic testing or a research result points toward SMG6, or for relatives who want to clarify their risk. Results may guide screening and family planning.

A genetic result is only one part of your health story

Genetic findings can be very informative, but what they can tell you varies based on the condition and the specific type of variant. How your body functions over the years is also shaped by factors like lifestyle, environment, age, and your medical history. With some conditions, particularly those affected by many genes, genetic details provide helpful background rather than a definite prediction and make the most sense when considered with the rest of your care. In other situations, a genetic result can offer a straightforward answer. For topics like how someone responds to medications, genetic results can also help put personal experiences in context.

Dr. Wallerstorfer Dr. Wallerstorfer

Pharmacogenetics

How variants shape your response to medicine

Genetic variation can affect how people respond to medicines, and not every gene has a clear, clinically used pharmacogenetic role. The SMG6 gene is not commonly used in routine prescribing decisions, but changes across many genes can still influence how quickly a drug is processed, how strongly it acts on its target, or how likely side effects are. This is one reason the same dose can feel very effective for one person yet less helpful or harder to tolerate for another. Your age, kidney and liver health, other medications, and overall health can also shape medication response alongside genetics.

What is Pharmacogenetics?

Pharmacogenetics is a branch of science that examines how differences in a person’s genes can affect the way they respond to medicines. It focuses on relationships between specific genes and particular drugs to explain why the same treatment can have different effects in different people. For many medications, genetic factors can influence how powerfully a drug works or how your body breaks it down. This information can support more informed decisions and a more individualized approach to treatment. More details on this topic are available in the LearnHub.


Drugs influenced by the SMG6 gene

There are 0 Drugs associated with SMG6
Currently no available information

When should I seek medical advice?

Seek medical advice if you or your child has a known SMG6 gene change and develops new or worsening learning, movement, or growth concerns, or symptoms that interfere with daily life. Talk with a clinician before starting, stopping, or changing medicines if you’re worried the SMG6 result could affect treatment. Get urgent care for weakness, seizures, trouble breathing, or confusion.

History

Research on the SMG6 gene grew out of a broader effort to understand how cells recognize and handle faulty genetic messages. In the late 1970s and 1980s, scientists described a quality control process now called nonsense mediated mRNA decay, after noticing that cells often reduced abnormal messages that would otherwise make shortened proteins. In the 1990s, genetic studies in the roundworm C. elegans identified a set of “smg” genes that were required for this process, laying the groundwork for finding related human genes. From these first observations, research expanded steadily. Over the 2000s, SMG6 became established as one of the core human SMG genes, and its role in this pathway was refined as modern sequencing and cell biology tools improved.

Literature

DISCLAIMER: The materials present on Genopedia.com, such as text, images, graphics, among other items (“Content”), are shared purely for informational reasons. This content should not replace professional health advice, medical diagnoses, or treatment procedures. Whenever you have health concerns or questions, it’s always recommended to engage with your doctor or another appropriate healthcare provider. If you read something on the Genopedia.com site, do not neglect professional medical counsel or delay in obtaining it. In case you believe you’re dealing with a medical crisis, get in touch with your medical professional or call emergency without delay. Genopedia.com doesn’t advocate for any particular medical tests, healthcare providers, products, methods, beliefs, or other data that could be discussed on the site. Please also note that the content, originally written in English and in part created with the help of artificial intelligence, is provided without any warranty, and any reliance on information offered by Genopedia.com, its staff, contributors invited by Genopedia.com, or site users is entirely at your own risk.
Genopedia © 2026 all rights reserved